The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sunvozertinib for the treatment of NSCLC with EGFR Exon20 insertion mutations: The first pivotal study results.
 
Mengzhao Wang
Consulting or Advisory Role - Dizal Pharma
 
Yun Fan
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Yongsheng Wang
No Relationships to Disclose
 
Yanqiu Zhao
No Relationships to Disclose
 
Bo Jin
No Relationships to Disclose
 
Ying Hu
No Relationships to Disclose
 
Zhigang Han
No Relationships to Disclose
 
Xia Song
No Relationships to Disclose
 
Anwen Liu
No Relationships to Disclose
 
Kejing Tang
No Relationships to Disclose
 
Ding Cuimin
No Relationships to Disclose
 
Li Liang
No Relationships to Disclose
 
Lin Wu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Hengrui Pharmaceutical; Innovent Biologics; Lilly; Merck; MSD; Pfizer; Roche
 
Junzhen Gao
No Relationships to Disclose
 
Jianghong Wang
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Jianying Zhou
No Relationships to Disclose
 
Yong He
No Relationships to Disclose
 
Li Zheng
No Relationships to Disclose